Cancer Related Fatigue in Patients Receiving Chemotherapy
Sponsor
Medical Center Alkmaar (Other)
Overall Status
Unknown status
CT.gov ID
NCT00261534
Collaborator
(none)
90
1
5.9
15.1
Study Details
Study Description
Brief Summary
The purpose of this study is to examine the degree of fatigue in patients receiving chemotherapy. Special interest goes out to the course of fatigue throughout five treatments and the actions taken by patients to reduce this fatigue.The correlation between fatigue and haemoglobin will also be subject of study.
Study Design
Study Type:
Observational
Observational Model:
Defined Population
Time Perspective:
Prospective
Official Title:
Outcomes Research on the Course of Cancer Related Fatigue Throughout Five Chemotherapy Treatments
Study Start Date
:
Jan 1, 2006
Study Completion Date
:
Jul 1, 2006
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Diagnosis of cancer requiring chemotherapy treatment
Exclusion Criteria:
-
Pregnancy
-
Psychological illness
-
Life expectancy less than three months
-
Lack of basic proficiency in Dutch
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Medical Centre Alkmaar | Alkmaar | Noord-Holland | Netherlands | 1815JD |
Sponsors and Collaborators
- Medical Center Alkmaar
Investigators
- Study Director: D. Hilarius, MSc, Medical Centre Alkmaar, Hospital Pharmacy
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00261534
Other Study ID Numbers:
- M05-057
First Posted:
Dec 5, 2005
Last Update Posted:
Sep 14, 2006
Last Verified:
Sep 1, 2006